Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.

A phase III randomised study, comparing treatment with fluorouracil, epidoxorubicin and methotrexate (FEMTX) with the best supportive care, was conducted in patients with unresectable or metastatic gastric cancer. During the period from July 1986 to June 1992, 41 patients were randomised to receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyrhönen, S., Kuitunen, T., Nyandoto, P., Kouri, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033628/
https://www.ncbi.nlm.nih.gov/pubmed/7533517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033628/
https://www.ncbi.nlm.nih.gov/pubmed/7533517

Ejemplares similares